Pascal and Francis Bibliographic Databases

Help

Search results

Your search

cc.\*:("002B20E02")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 44853

  • Page / 1795

Export

Selection :

  • and

A Regulatory Loop Involving miR-22, Sp1, and c-Myc Modulates CD147 Expression in Breast Cancer Invasion and MetastasisKONG, Ling-Min; LIAO, Cheng-Gong; YANG ZHANG et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 14, pp 3764-3778, issn 0008-5472, 15 p.Article

Dépistage des cancers du sein par mammographie: Comparaisons non randomisées: résultats voisins de ceux des essais randomisés : Dépistage des cancers du sein par mammographieLa Revue Prescrire. 2014, Vol 34, Num 373, pp 842-846, issn 0247-7750, 5 p.Article

Critical role for reactive oxygen species in apoptosis induction and cell migration inhibition by diallyl trisulfide, a cancer chemopreventive component of garlicKUMAR HANDRA-KUNTAL; JOOMIN LEE; SINGH, Shivendra V et al.Breast cancer research and treatment. 2013, Vol 138, Num 1, pp 69-79, issn 0167-6806, 11 p.Article

Epigenetic Regulation by Z-DNA Silencer Function Controls Cancer-Associated ADAM-12 Expression in Breast Cancer: Cross-talk between MeCP2 and NF1 Transcription Factor FamilyRAY, Bimal K; DHAR, Srijita; HENRY, Carolyn et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 2, pp 736-744, issn 0008-5472, 9 p.Article

Peroxiredoxin Overexpression in MCF-7 Breast Cancer Cells and Regulation by Cell Proliferation and Oxidative StressTEHAN, Lauren; TAPARRA, Kekoa; PHELAN, Shelley et al.Cancer investigation. 2013, Vol 31, Num 1-10, pp 374-384, issn 0735-7907, 11 p.Article

CA 15-3 is a predictive and prognostic biomarker in patients with metastasized breast cancer undergoing Selective Internal Radiation TherapyFAHMUELLER, Yvonne Nadine; NAGEL, Dorothea; HOFFMANN, Ralf-Thorsten et al.International journal of clinical pharmacology and therapeutics. 2013, Vol 51, Num 1, pp 63-66, issn 0946-1965, 4 p.Conference Paper

18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniquesKOOLEN, Bas B; VRANCKEN PEETERS, Marie-Jeanne T. F. D; RUTGERS, Emiel J. Th et al.Breast cancer research and treatment. 2012, Vol 131, Num 1, pp 117-126, issn 0167-6806, 10 p.Article

Tumeur desmoide sur prothèse mammaireGERGELE, F; GUY, F; COLLIN, F et al.Journal de radiologie (Paris). 2012, Vol 93, Num 3, pp 219-221, issn 0221-0363, 3 p.Article

A PHASE II STUDY OF RADIOTHERAPY AND CONCURRENT PACLITAXEL CHEMOTHERAPY IN BREAST-CONSERVING TREATMENT FOR NODE-POSITIVE BREAST CANCERCHEN, William C; KIM, Janice; LYONS, Janice A et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 1, pp 14-20, issn 0360-3016, 7 p.Article

A randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivorsLAVIGNE, Jill E; HECKLER, Charles; MATHEWS, Jennifer L et al.Breast cancer research and treatment. 2012, Vol 136, Num 2, pp 479-486, issn 0167-6806, 8 p.Article

Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based studyWIGERTZ, Annette; AHLGREN, Johan; HOLMQVIST, Marit et al.Breast cancer research and treatment. 2012, Vol 133, Num 1, pp 367-373, issn 0167-6806, 7 p.Article

Adjuvant bisphosphonate treatment for breast cancer: Why did something so elegant become so complicated?CLEMONS, Mark; RUSSELL, Kent; COSTA, Luis et al.Breast cancer research and treatment. 2012, Vol 134, Num 2, pp 453-457, issn 0167-6806, 5 p.Article

Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancerITO, Tokiko; KAMIJO, Shinobu; IZUMI, Hiroto et al.Breast cancer research and treatment. 2012, Vol 133, Num 1, pp 145-159, issn 0167-6806, 15 p.Article

Analysis of KLLN as a high-penetrance breast cancer predisposition geneTHOMPSON, Ella R; GORRINGE, Kylie L; CHOONG, David Y. H et al.Breast cancer research and treatment. 2012, Vol 134, Num 2, pp 543-547, issn 0167-6806, 5 p.Article

Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancerINAO, Touko; HARASHIMA, Nanae; MONMA, Hiroyuki et al.Breast cancer research and treatment. 2012, Vol 134, Num 1, pp 89-100, issn 0167-6806, 12 p.Article

Assessing the RNA effect of 26 DNA variants in the BRCA1 and BRCA2 genesMENENDEZ, Mireia; CASTELLSAGUE, Joan; QUILES, Francisco et al.Breast cancer research and treatment. 2012, Vol 132, Num 3, pp 979-992, issn 0167-6806, 14 p.Article

Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancerHEUSINGER, Katharina; JUD, Sebastian M; RAUH, Claudia et al.Breast cancer research and treatment. 2012, Vol 135, Num 3, pp 885-892, issn 0167-6806, 8 p.Article

Basal-like breast cancer stem cells are sensitive to anti-DR5 mediated cytotoxicityLONDONO-JOSHI, Angelina I; OLIVER, Patsy G; YUFENG LI et al.Breast cancer research and treatment. 2012, Vol 133, Num 2, pp 437-445, issn 0167-6806, 9 p.Article

Breast cancer incidence trends in European women aged 20―39 years at diagnosisMERLO, D. F; CEPPI, M; FILIBERTI, R et al.Breast cancer research and treatment. 2012, Vol 134, Num 1, pp 363-370, issn 0167-6806, 8 p.Article

Breast tenderness after initiation of conjugated equine estrogens and mammographic density changeCRANDALL, Carolyn J; ARAGAKI, Aaron K; CAULEY, Jane A et al.Breast cancer research and treatment. 2012, Vol 131, Num 3, pp 969-979, issn 0167-6806, 11 p.Article

Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women's health initiative clinical trialsCRANDALL, Carolyn J; ARAGAKI, Aaron K; CAULEY, Jane A et al.Breast cancer research and treatment. 2012, Vol 132, Num 1, pp 275-285, issn 0167-6806, 11 p.Article

CONTRALATERAL BREAST DOSE AFTER WHOLE-BREAST IRRADIATION: AN ANALYSIS BY TREATMENT TECHNIQUEWILLIAMS, Terence M; MORAN, Jean M; HSU, Shu-Hui et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 5, pp 2079-2085, issn 0360-3016, 7 p.Article

Chemotherapy-related cognitive impairment: does integrating complementary medicine have something to add? Review of the literatureAVISAR, Adva; RIVER, Yaron; SCHIFF, Elad et al.Breast cancer research and treatment. 2012, Vol 136, Num 1, pp 1-7, issn 0167-6806, 7 p.Article

Clinical and biomarker predictors of side effects from tamoxifenLORIZIO, Wendy; WU, Alan H. B; BEATTIE, Mary S et al.Breast cancer research and treatment. 2012, Vol 132, Num 3, pp 1107-1118, issn 0167-6806, 12 p.Article

Common Variants of GSTP1, GSTA1, and TGFβ1 are Associated With the Risk of Radiation-Induced Fibrosis in Breast Cancer PatientsTERRAZZINO, Salvatore; LA MATTINA, Pierdaniele; GAMBARO, Giuseppina et al.International journal of radiation oncology, biology, physics. 2012, Vol 83, Num 2, pp 504-511, issn 0360-3016, 8 p.Article

  • Page / 1795